会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Methods relating to immunogenic dextran-protein conjugates
    • 与免疫原性葡聚糖 - 蛋白质共轭物相关的方法
    • US06287568B1
    • 2001-09-11
    • US09149997
    • 1998-09-09
    • Denong WangBernard F. ErlangerElvin A. Kabat
    • Denong WangBernard F. ErlangerElvin A. Kabat
    • A01N6500
    • A61K47/646A61K47/61Y10S424/804Y10S424/812
    • This invention includes the conception of T-independent conjugate-vaccines and its application in the induction of antigen specific IgA response. We demonstrated that 1) &agr;(1,6)dextran can elicit a markedly enhanced IgA response in T-cell free mice (20-50 fold higher than in normal mice); 2)co-injection of the molecule with other antigens can enhance the IgA response to the co-antigen; and 3)a dextran-Gag conjugate can elicit the Gag-specific IgA. Thus, the invention identified &agr;(1,6)dextran as a carrier molecule for producing the T-independent conjugates and as an adjuvant for the enhancement of IgA production. The T-independent property of these conjugates makes it especially useful in vaccinations against HIV and other infectious and non-infectious diseases associated with T-cell deficiency.
    • 本发明包括T非依赖性缀合物疫苗的概念及其在诱导抗原特异性IgA应答中的应用。 我们证明1)α(1,6)葡聚糖可以在无T细胞的小鼠中引起显着增强的IgA反应(比正常小鼠高20-50倍); 2)共注射分子与其他抗原可以增强对共抗原的IgA反应; 和3)葡聚糖-Gag缀合物可以引发Gag特异性IgA。 因此,本发明鉴定了α(1,6)葡聚糖作为产生T非依赖性缀合物的载体分子和用于增强IgA产生的佐剂。 这些缀合物的T独立性质使其特别适用于针对HIV和与T细胞缺乏相关的其他感染性和非感染性疾病的疫苗接种。
    • 5. 发明授权
    • Antibodies specific for fullerenes
    • 富勒烯特异性抗体
    • US06593137B1
    • 2003-07-15
    • US09386658
    • 1999-08-31
    • Bernard F. ErlangerBi-Xing Chen
    • Bernard F. ErlangerBi-Xing Chen
    • C12N520
    • B82Y30/00B82Y5/00C07K16/44G01N33/5308G01N2430/00Y10S530/807
    • This invention provides a hybridoma produced by the fusion of a mouse antibody-producing cell and a mouse myeloma which is designated 1-10F-8A and deposited with the ATCC under Accession Number PTA-279, said hybridoma producing a monoclonal antibody which binds to fullerene C60. This invention provides a mouse monoclonal antibody specific for a fullerene-C60 and produced by the mouse monoclonal antibody-producing hybridoma designated 1-10F-8A. The invention provides the amino acid and encoding nucleic acid sequences of the heavy and light chains of the 1-10F-8A monoclonal antibody. This invention also provides methods of determining a serum concentration of a fullerene in a subject and of purifying a fullerene from a sample.
    • 本发明提供了通过将小鼠抗体产生细胞与小鼠骨髓瘤融合而产生的杂交瘤,其被命名为1-10F-8A,并以保藏号PTA-279保藏在ATCC中,所述杂交瘤产生结合富勒烯的单克隆抗体 C60。 本发明提供了对富勒烯-C60特异性并由指定为1-10F-8A的产生小鼠单克隆抗体的杂交瘤产生的小鼠单克隆抗体。 本发明提供1-10F-8A单克隆抗体的重链和轻链的氨基酸和编码核酸序列。 本发明还提供了确定受试者中富勒烯的血清浓度并从样品中纯化富勒烯的方法。
    • 10. 发明授权
    • Method of producing monoclonal auto-anti-idiotypic antibodies
    • 单克隆抗体独特型抗体的制备方法
    • US5144010A
    • 1992-09-01
    • US273654
    • 1989-11-18
    • Bernard F. ErlangerWilliam L. Cleveland
    • Bernard F. ErlangerWilliam L. Cleveland
    • C07K16/42
    • C07K16/4241Y10S530/809
    • This invention provides an auto-anti-idiotypic method for producing a monoclonal anti-idiotypic antibody. The method involves contacting lymphoid cells of an animal under suitable conditions with an effective antibody-raising amount of an antigen, collecting the lymphoid cells from the animal at a suitable time after the contacting and fusing the collected lymphoid cells with appropriate myeloma cells to produce a series of hybridoma cells each of which produces a monoclonal antibody. The method further involves screening, under suitable conditions, the series of hybridoma cells so produced to identify those which secrete a monoclonal antibody capable of binding to an antibody directed to the antigen, or to a receptor where the antigen is a ligand to the receptor, separately culturing a hybridoma cell so identified in an appropriate medium, and separately recovering under suitable conditions the monoclonal anti-idiotypic antibody produced by the hybridoma cell.
    • 本发明提供了用于产生单克隆抗独特型抗体的自身抗独特型方法。 该方法包括在合适的条件下将动物的淋巴样细胞与有效的抗体提高量的抗原接触,并在收集的淋巴样细胞与合适的骨髓瘤细胞接合并融合后,在合适的时间从动物收集淋巴样细胞以产生 一系列杂交瘤细胞各自产生单克隆抗体。 该方法还包括在合适的条件下筛选如此产生的一系列杂交瘤细胞,以鉴定分泌能够结合针对抗原的抗体的单克隆抗体的那些,或者其中抗原是受体的配体的受体, 分别培养在合适的培养基中鉴定的杂交瘤细胞,并在合适的条件下分别回收由杂交瘤细胞产生的单克隆抗独特型抗体。